Revenue of $278.2 million, up 46% year-over-year in 2024
Net income of $11.1 million; Adjusted EBITDA of $32.3 million in Q1 2024
Subscribers grew to 1.7 million, up 41% year-over-year in Q1.
Hims & Hers Health Q3: The Cheapest Growth Stock Around (NYSE:HIMS) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Revenue of $226.7 million, up 57% year-over-year in Q3 2023
Net loss of $7.6 million; Adjusted EBITDA profitability of $12.3 million in Q3 2023
Subscribers grew to 1.4 million, up 56%.
Revenue of $207.9 million, up 83% year-over-year in Q2 2023
Net loss of $7.2 million; Adjusted EBITDA profitability of $10.6 million in Q2 2023
Subscribers grew to 1.3 million, up 74%.
Wirksamkeit der Corona-Impfstoffe: Beeinflussen Alter, Geschlecht und Körpergewicht Impfschutz? infranken.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infranken.de Daily Mail and Mail on Sunday newspapers.